1,2,3,4-TETRAHYDRO-1,3-DIMETHYL-BETA,2,4-TRIOXO-6-(PHENYLAMINO)-5-PYRIMIDINEPROPANENITRILE (132373-29-6)

Identification
Name:	1,2,3,4-TETRAHYDRO-1,3-DIMETHYL-BETA,2,4-TRIOXO-6-(PHENYLAMINO)-5-PYRIMIDINEPROPANENITRILE
Synonyms:	1,2,3,4-TETRAHYDRO-1,3-DIMETHYL-BETA,2,4-TRIOXO-6-(PHENYLAMINO)-5-PYRIMIDINEPROPANENITRILE
CAS:	132373-29-6
Molecular Formula:	C15H14N4O3
Molecular Weight:	0
Molecular Structure:
Properties
Safety Data

Other Product

6-(ETHYLAMINO)-1,2,3,4-TETRAHYDRO-1,3-DIMETHYL-BETA,2,4-TRIOXO-5-PYRIMIDINEPROPANENITRILE
1(2H)-Pyrimidinepropanenitrile,tetrahydro-3-[4-[(phenylmethylene)amino]butyl]-
5-Pyrimidinepropanenitrile,2-amino-1,6-dihydro-6-oxo-4-phenyl-
5-Pyrimidinepropanenitrile,2-amino-1,6-dihydro-4-methyl-6-oxo-
5-Pyrimidinepropanenitrile,6-amino-1,2,3,4-tetrahydro-1,3-dimethyl-b,2,4-trioxo-
1-beta,2-alpha-CHRYSENEDIOL, 1,2,3,4-TETRAHYDRO-3-beta,4-beta-EPOXY-, (Z)-(-)-
Benzenesulfonamide,2-[3-cyclohexyl-5-[[4-(dimethylamino)phenyl]methylene]tetrahydro-2,4,6-trioxo-1(2H)-pyrimidinyl]-
1,4-Benzenedicarboxylic acid,2-[3-carboxy-5-hydroxy-4-[3-(1,3,4,6-tetrahydro-1,3-dimethyl-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1-propenyl]-1H-pyrazol-1-yl]-
Acetamide, N-5-bromo-2,3,4,6-tetrakis(acetyloxy)cyclohexyl-, (1.alpha.,2.beta.,3.beta.,4.alpha.,5.beta.,6.alpha.)-
2-Pyridinecarboxylic acid,5-[5-[[1-(6-carboxy-3-pyridinyl)hexahydro-3-(2-hydroxyethyl)-2,4,6-trioxo-5-pyrimidinyl]methylene]tetrahydro-3-(2-hydroxyethyl)-2,4,6-trioxo-1(2H)-pyrimidinyl]-
3,4-Piperidinediol, 1,3-dimethyl-4-ethyl-6-(2-methylphenyl)-, (1-alpha,3-alpha,4-beta,6-beta)-
Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro- 4-hydroxy- 6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha-(R*),3-alpha,7-beta, 8-beta-(2S*,4S*),8a-beta))-
(5'beta)-5'-ethyl-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
Morpholine,4-[[2-[3-cyclohexyl-5-[[4-(dimethylamino)phenyl]methylene]tetrahydro-2,4,6-trioxo-1(2H)-pyrimidinyl]phenyl]sulfonyl]-
Benzenesulfonamide,2-[5-[[4-[bis(2-cyanoethyl)amino]phenyl]methylene]tetrahydro-2,4,6-trioxo-3-phenyl-1(2H)-pyrimidinyl]-
5-(O-(3-O-(6-Amino-6-deoxy-beta-idopyranosyl)-beta-ribofuranosyl)-1-N-4-amino-2-hydroxybutanoyl)-3-deoxyparomamine
ALPHA-NEU5AC-[2->6]-BETA-GAL-[1->4]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC SODIUM SALT
2-Quinazolineacetonitrile,a-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-3,4-dihydro-4-oxo-
Benzoic acid,4-[[5-[3-[1-[(4-carboxyphenyl)methyl]hexahydro-3-(2-hydroxyethyl)-2,4,6-trioxo-5-pyrimidinyl]-2-propenylidene]tetrahydro-3-(2-hydroxyethyl)-2,4,6-trioxo-1(2H)-pyrimidinyl]methyl]-
3-Oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 9,9-dimethyl-7-((1-oxo-2-propylpentyl)oxy)-, bromide, (1-alpha,2-beta,4-beta,5-alpha,7-beta)-